| 000 | 01678 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514015704.0 | ||
| 264 | 0 | _c20011220 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhong, Z | |
| 245 | 0 | 0 |
_aCyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 2001 |
||
| 300 |
_a858-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 |
_aCyclosporine _xtoxicity |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 |
_aEating _xdrug effects |
| 650 | 0 | 4 |
_aGlycine _xtherapeutic use |
| 650 | 0 | 4 |
_aHypoxia _xchemically induced |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtoxicity |
| 650 | 0 | 4 |
_aKupffer Cells _xdrug effects |
| 650 | 0 | 4 |
_aLiver Diseases _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitochondria, Liver _xdrug effects |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aUrea _xmetabolism |
| 700 | 1 | _aLi, X | |
| 700 | 1 | _aYamashina, S | |
| 700 | 1 | _avon Frankenberg, M | |
| 700 | 1 | _aEnomoto, N | |
| 700 | 1 | _aIkejima, K | |
| 700 | 1 | _aKolinsky, M | |
| 700 | 1 | _aRaleigh, J A | |
| 700 | 1 | _aThurman, R G | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 299 _gno. 3 _gp. 858-65 |
|
| 999 |
_c11629457 _d11629457 |
||